How immune receptors affect brain function after traumatic brain injury
Contribution of Innate Immune Receptors to Neurological Dysfunction After Traumatic Brain Injury: Mechanisms and Therapeutic Implications
This study is looking at how certain immune receptors in the brain might affect memory loss and seizures after a traumatic brain injury, with the goal of finding ways to help prevent long-term problems for people who have experienced such injuries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-11061096 on NIH RePORTER |
What this research studies
This research investigates the role of innate immune receptors in the development of neurological disorders following traumatic brain injury (TBI). It focuses on understanding how TBI leads to memory loss and seizures over time, particularly examining the hippocampal dentate gyrus, which is crucial for memory processing. The study aims to explore the effects of neurogenesis and the immune receptor TLR4 on brain excitability and memory function after injury. By identifying these mechanisms, the research seeks to uncover potential early interventions that could mitigate long-term neurological damage.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have experienced a traumatic brain injury.
Not a fit: Patients with neurological disorders unrelated to traumatic brain injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that prevent or reduce memory loss and seizures in individuals who have suffered a traumatic brain injury.
How similar studies have performed: Previous research has shown promising results in understanding the role of immune receptors in brain function, suggesting that this approach could yield significant insights.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Santhakumar, Vijayalakshmi — University of California Riverside
- Study coordinator: Santhakumar, Vijayalakshmi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.